Viridian Therapeutics, Inc.\DE

VRDNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.432 B

$23.59 +4.80%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$342.6M

Loss-making

Shares outstanding

113,292,269

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#93Amylyx PharmaceuticalsAMLX$2.54B
#94PharvarisPHVS$2.43B
#95Viridian Therapeutics, Inc.\DEVRDN$2.43B
#96Kailera TherapeuticsKLRA$2.42B
#97Vera TherapeuticsVERA$2.36B

Where these numbers come from

Share counts and financials for Viridian Therapeutics, Inc.\DE are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.